111 related articles for article (PubMed ID: 17888100)
1. Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals.
Smith KJ; Cook RL; Roberts MS
Value Health; 2007; 10(5):358-66. PubMed ID: 17888100
[TBL] [Abstract][Full Text] [Related]
2. Cost and effectiveness of Chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners.
Nevin RL; Shuping EE; Frick KD; Gaydos JC; Gaydos CA
Sex Transm Dis; 2008 Aug; 35(8):705-13. PubMed ID: 18461015
[TBL] [Abstract][Full Text] [Related]
3. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?
Shafer MA; Pantell RH; Schachter J
Arch Pediatr Adolesc Med; 1999 Feb; 153(2):119-25. PubMed ID: 9988241
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization for pelvic inflammatory disease: a cost-effectiveness analysis.
Smith KJ; Ness RB; Roberts MS
Sex Transm Dis; 2007 Feb; 34(2):108-12. PubMed ID: 16794559
[TBL] [Abstract][Full Text] [Related]
5. The cost effectiveness of opportunistic chlamydia screening in England.
Adams EJ; Turner KM; Edmunds WJ
Sex Transm Infect; 2007 Jul; 83(4):267-74; discussion 274-5. PubMed ID: 17475686
[TBL] [Abstract][Full Text] [Related]
6. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
[TBL] [Abstract][Full Text] [Related]
7. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
8. Sex workers can be screened too often: a cost-effectiveness analysis in Victoria, Australia.
Wilson DP; Heymer KJ; Anderson J; O'Connor J; Harcourt C; Donovan B
Sex Transm Infect; 2010 Apr; 86(2):117-25. PubMed ID: 19843534
[TBL] [Abstract][Full Text] [Related]
9. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial.
Aghaizu A; Adams EJ; Turner K; Kerry S; Hay P; Simms I; Oakeshott P
Sex Transm Infect; 2011 Jun; 87(4):312-7. PubMed ID: 21444333
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of a school-based sexually transmitted disease screening program.
Wang LY; Burstein GR; Cohen DA
Sex Transm Dis; 2002 Dec; 29(12):737-45. PubMed ID: 12466713
[TBL] [Abstract][Full Text] [Related]
11. Sexually transmitted disease screening in teens.
Huppert JS; Adams Hillard PJ
Curr Womens Health Rep; 2003 Dec; 3(6):451-8. PubMed ID: 14613666
[TBL] [Abstract][Full Text] [Related]
12. The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies.
Hu D; Hook EW; Goldie SJ
Sex Transm Dis; 2006 Jul; 33(7):428-36. PubMed ID: 16572038
[TBL] [Abstract][Full Text] [Related]
13. Use age to target chlamydial screening.
Contracept Technol Update; 1998 Aug; 19(8):104-5. PubMed ID: 12348576
[TBL] [Abstract][Full Text] [Related]
14. Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.
Herzog SA; Heijne JC; Scott P; Althaus CL; Low N
Epidemiology; 2013 Nov; 24(6):854-62. PubMed ID: 24076992
[TBL] [Abstract][Full Text] [Related]
15. A refined estimate of the average lifetime cost of pelvic inflammatory disease.
Yeh JM; Hook EW; Goldie SJ
Sex Transm Dis; 2003 May; 30(5):369-78. PubMed ID: 12916126
[TBL] [Abstract][Full Text] [Related]
16. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
17. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease.
Trent M; Chung SE; Forrest L; Ellen JM
Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1022-5. PubMed ID: 18981349
[TBL] [Abstract][Full Text] [Related]
18. Pelvic inflammatory disease in adolescents.
Igra V
AIDS Patient Care STDS; 1998 Feb; 12(2):109-24. PubMed ID: 11361905
[TBL] [Abstract][Full Text] [Related]
19. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
Gottlieb SL; Xu F; Brunham RC
Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
